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Abstract
Objectives: To study the value of demographic and alcohol-related variables for predicting 24-
month treatment outcome in an outpatient setting.
Methods: Prospective observational study with 92 alcohol-dependent patients. Assessments were
made by personal interviews at the beginning and end of therapy, and at the 24-month follow-up.
Univariate and logistic regression analyses were performed.
Results: The mean age was 46.0 (SD = 9.9) years. There were 58 males (65.2%) and 31 females
(34.8%). Of the 67 patients interviewed at 2-year follow-up, 58% were abstinent and 79% improved.
Differences between abstainers and non-abstainers were found for number of previous
detoxifications, and number of patients attempted suicides. In addition, female gender and a higher
number of prior treatments predicted negative treatment outcome.
Conclusion: Matching patients to different types of treatment by means of empirically based
characteristics may help to improve outcome but research has failed to establish reliable predictors
in that area. Data from this follow-up study confirm the role of certain clinical outcome predictors.
Additionally, results give further evidence for outpatient treatment as an effective setting for
alcohol-dependent patients as indicated by a favourable retention rate (84%) and outcome
(minimum abstinence rate 44%).
Background
Setting and gender effects play a substantial role in treat-
ment of alcoholism. Variables that may predict treatment
outcome are of great relevance for optimal allocation of
patients to different treatment settings [1-5]. In Germany
and other European countries in recent years highly struc-
tured outpatient treatment programs have been devel-
oped and partially replaced longer inpatient treatment as
indicated by a larger number of patients in outpatient
clinics but few follow-up studies have been published on
the efficacy of these treatments [6]. Variables that were
found to be predictive in inpatient treatment [7] do not
necessarily have to be so in other treatment settings.
Favourable 3-year outcome results for an intensive alco-
hol outpatient treatment programme were found in an
earlier study [8]. Furthermore, this study identified female
gender, number of previous treatments, relapse during
treatment, duration of relapse during treatment, treat-
ment drop out and attempted suicides as risk factors for a
negative treatment outcome. Identification of predictors
should allow improvement of treatment outcome and
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allocation of patients to the most suitable treatment set-
ting as well as a reduction in the number of treatment fail-
ures. A number of different variables are being discussed
as potential predictors of treatment outcome. Besides bio-
logical parameters such as the GABRA2 genotype [9], the
following variables were generated in a literature review.
- Demographics and social functioning measures:
employment, gender, socioeconomic status/income, reli-
gion [8,10-26],
- Substance-related measures: baseline alcohol consump-
tion, dependence severity, treatment history, alcohol-
related self-efficacy, motivation, treatment goal, duration
of problem drinking/alcohol dependence, baseline alco-
hol consumption, craving, [10-13,17,27],
- Other clinical measures: psychopathology rating, neu-
ropsychological functioning [10-14,28-35].
Identification of reliable outcome predictors should help
to improve patient allocation and consequently the utili-
zation of resources. Hence the main objective of this study
is to evaluate the value of demographic, alcohol-related
variables, and psychopathology-related variables for pre-
dicting 24-month treatment outcome. In this study we
tried to confirm previous research concerning predictors
of outcome in an elaborated outpatient treatment setting
[8].
According to the previous results we will examine the
hypothesis that female gender and treatment drop out are
the strongest predictors for relapsing after treatment.
Methods
Study design
This was a prospective observational study. The method-
ology and research instruments were basically the same as
those used in a previous study performed in the same
treatment setting [8]. The study was conducted at the out-
patient facility "Client-oriented Problem Advice Centre
Dachau", near Munich. This centre offers a highly struc-
tured, intensive, two-phase treatment model. Treatment
starts with a three-month motivational phase immedi-
ately after detoxification. This phase includes a detailed
medical/neurological and psycho-diagnostic examina-
tion. Patients are seen on several days per week. They
attend a weekly group therapy session and four individual
psychotherapy/medical sessions. The motivational phase
is followed by an 8-month rehabilitation phase which is
the object of research. The therapy concept is integrative
and eclectic, and includes psychoanalytical as well as
behavioural approaches and methods (three weekly ses-
sions). It is an intensive abstinence-oriented program
which was described in detail by Bottlender and Soyka
[36].
From January to December 2003, 92 alcohol-dependent
patients were consecutively recruited at the start of the
outpatient rehabilitation. This was all of the patients
(100%) which fulfilled the inclusion criteria defined by
health care providers; no formal screening took place.
Most patients referred by (family) physician or employer.
Patients fulfilled the DSM-IV [37] criteria for alcohol
dependence. A further inclusion criterion was a stable res-
idential situation. Exclusion criteria were dependence of
benodiazepines and/or illicit drugs, severe physical ill-
ness, severe mental disorders and mental disorders requir-
ing inpatient treatment (acute suicidality, psychosis). All
patients who entered treatment participated in the study.
All patients gave written informed consent to participate
in the study.
Assessment
Both diagnoses and variables relevant for the analyses
were recorded in structured face-to-face interviews. Inter-
views used the European Addiction Severity Index (Euro-
pASI: German version) [38] and were conducted with
each patient at the start of the programme (Baseline, T0),
at discharge from the treatment unit (T1) and at the 24-
month follow-up (T4). The baseline assessment included
demographics, past and current psychiatric, medical and
substance use-related problems, and drinking parameters.
According treatment history the patients were asked about
prior detoxification, prior alcohol rehabilitation, and
prior treatments for psychiatric problems except for alco-
holism. The variable 'suicide attempts' means the lifetime
suicide attempts before T0. At discharge the length of time
spent in the programme, mode of discharge from the pro-
gramme (e.g. successfully completed the programme, left
prematurely by choice, etc.) and relapses during treatment
were recorded. The interviewers were trained psycholo-
gists, physicians and medical students and were not
involved in the treatment of interviewed subjects; the
project coordinator was not a member of the clinical staff.
At T1, patients completed the self-rating Obsessive Com-
pulsive Drinking Scale (OCDS) [[39], German version:
[40]] and at T0 the self-rating Beck Depression Inventory
(BDI) [41] and the state scale of the State-Trait-Anxiety
Inventory (STAI) [42].
Furthermore, abstinence was checked by breathalyser dur-
ing the entire treatment period as well as at every visit after
treatment. In table 1 variables, assessment instruments
and assessment times are summarized.
Definition of outcome criteria
Abstinence two years after discharge from treatment was
the primary outcome criterion. Abstinence was defined as
no subjective report or objective indication of alcohol
consumption since discharge from treatment. This crite-
rion was used in the data analyses as dependent variable.Substance Abuse Treatment, Prevention, and Policy 2009, 4:15 http://www.substanceabusepolicy.com/content/4/1/15
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Moreover, in the outcome description the number of
patients who completed treatment and the number of
improved patients were recorded. 'Improved' was defined
according to the classification by Feuerlein and Küfner [7]
as less than 30 g (female) or 60 g (male) of alcohol per
day, no signs of physical or mental consequences of alco-
hol abuse or of any pathological drinking pattern, or no
more than three drinking periods lasting less than a week
(lapses) since discharge from treatment; 'relapse'  was
defined as more than three lapses or regular consumption
of more than 30/60 g alcohol per day, newly appeared
alcohol-related disorders and/or alcohol inpatient treat-
ments.
Furthermore, patients who personally interviewed at the
24-month follow-up were named 'responder'. Non-
responders are patients who missed the 24-month follow-
up interview. Regarding the sample size, we performed
both, the analyse limited to responders vs. analyse includ-
ing non-responders as relapsers. No significant difference
resulted.
Data analyses
Statistical analyses were performed using SPSS for Win-
dows [43]. Absolute and relative frequencies, means and
standard deviations (SD) were calculated for data descrip-
tion. Abstinent and non-abstinent patients as well as
responders and non-responders were compared univariat
with Chi2 by Pearson (alternative and categorial data),
Mann-Whitney-U-test (ordinal data), Kolmogorov-Smir-
nov-test (metric data) and with backward stepwise logistic
regression analyses. In account of the small sample size
and the lot of variables we would like to integrate in the
analyses, we followed the three steps for model building
described by Hosmer and Lemeshow [44] to identify
meaningful predictors of outcome. The model is useful for
modelling of complex data sets. The process began with
univariate analysis for checking potential predictors (Step
1). Step 2 was the manual selection of variables for the
multivariate analysis. According to Mickey and Greenland
[45] variables whose univariate p-value < 0.25 were candi-
dates for the multivariate analyse. In a third step the
importance of each variable integrated in the model was
verified and we obtained a preliminary main effects
model. This third step included a manual selection of the
most important predictor of each category (demograph-
ics, substance-related variables and other clinical meas-
ures).
Independent variables included in the analyses were:
- Demographics: age, gender, education (school and profes-
sional qualifications), employment status, living circum-
stances, marital status and socioeconomic status/income
(kind of income),
- Substance-related variables onset of alcohol use, onset for
problem drinking, onset of alcohol dependence, baseline
alcohol consumption, craving (OCDS-score), dependence
severity (EuropASI) and treatment history,
- psychopathology-related variables (other clinical measures):
attempted suicide, psychopathology rating (EuropASI),
prior psychiatric treatment and symptoms of depression
or anxiety (scores of BDI and STAI).
All statistical tests were two-tailed. A p-value of less than
0.05 was considered to be statistically significant. Regard-
ing the sample size, we performed both, the analyse lim-
ited to responders vs. analyse including non-responders as
relapsers. No significant difference resulted.
Results
Of the 92 patients enrolled in the study, 77 (83.7%) com-
pleted the full outpatient treatment. Two male and one
female patient became seriously ill (apoplexy, cerebral
haemorrhage, laryngeal carcinoma) and were excluded
from further analyses (3 of 92). Data from 67 patients
(75.3% of 89) were available for analysis 24 months after
discharge: The other 22 patients (24.7%) did not take part
in the 24-month follow-up because they declined further
participation (n = 13; 14.6%), their new address was
unknown (despite a search by the registration office: n =
6; 6.7%) or they could not be contacted despite several
attempts (n = 3; 3.4%). Of the interviewed sample (n =
67), 58.2% patients (n = 39) were abstinent and 79.1%
Table 1: Variables, assessment instruments and assessment times
T0 T1 T2 T3 T4
Treatment start At discharge 6 months after discharge 12 months after discharge 24 months after discharge
EuropASI/patient files:
Demographics
Psychiatric, medical and 
substance use problems
Drinking parameters
EuropASI/patient files:
Time in treatment
Mode of discharge
Relapses
Not relevant for this study Total abstinence during the 24 
months
"Improved"
Relapse
BDI OCDS
STAISubstance Abuse Treatment, Prevention, and Policy 2009, 4:15 http://www.substanceabusepolicy.com/content/4/1/15
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patients (n = 53) were abstinent or improved at the 24-
month follow-up. If all patients without follow-up data
were assumed to be relapsers, 43.8% patients (39 of 89)
were abstinent and 59.6% (53 of 89) were abstinent or
improved.
Patients' characteristics and results of the univariate 
comparison of abstainers and non-abstainers (T4)
The study sample consisted of 58 males (65.2%) and 31
females (34.8%). At admission, the mean age of the
patients was 46.0 (SD = 9.9) years. Patients were socially
well integrated: Many were married (47.2%), lived
together with a partner and children (55.0%) and were
employed (75.3%). Further demographic variables are
shown in table 2.
Alcohol-related as well as psychopathology-related varia-
bles are shown in table 3. The average duration of alcohol
dependence was 13.6 (SD = 9.3) years and the mean age
of onset of alcohol dependence 32.1 years (SD = 10.4).
Abstainers and non-abstainers differed in the number of
previous detoxifications. On average, the non-abstainers
had participated in more alcohol detoxifications (4.7; SD
= 7.5) than the abstainers (2.5; SD = 4.9).
Furthermore, abstainers and non-abstainers differed in
attempted suicides until T0: 25% of the non-abstinent
patients had attempted at least one suicide, while this rela-
tion for the abstainers was 7.7%. No significant differ-
ences were found in the results of STAI, BDI or OCDS.
With reference to the three steps for model building, we
selected the following variables with an univariate p-value
less than 0.25 as candidates for the multivariate analyse:
gender, number of previous detoxifications, number of
prev. mental health problems, number of prev. somatic
problems, treatment drop out, repeated relapse during
treatment, attempted suicide, the BDI score, and the
OCDS total score.
Table 2: Differences in demographic variables (T0) between abstinent and non-abstinent patients at 24-month follow-up (T4)
Total sample Patients responded T4 (n = 67) Differences abstinent vs. non-
abstinent
(n = 89) abstinent T4 (n = 39) non-abstinent T4 (n = 28)
Age (M, SD) 46.0 (9.9) 47.0 (9.2) 46.1 (1.6) n.s.
Gender (n, %)
Male 58 (65.2) 26 (66.6) 15 (53.6) Pearson Chi2 = 0.84a; df = 1
Female 31 (34.8) 13 (33.3) 13 (46.3)
Without secondary school 
qualifications (n, %)
1 (1.1) 1 (2.6) 0 n.s.
Without professional training (n, %) 14 (15.7) 5 (12.8) 4 (14.3) n.s.
Livelihood (n, %) n.s.
Gainful employment 67 (75.3) 34 (87.2) 18 (64.3)
Unemployment benefit 7 (7.8) 1 (2.6) 3 (10.7)
Pension 7 (7.8) 2 (5.2) 4 (14.3)
Support by relatives 5 (5.6) 1 (2.6) 2 (7.1)
Other 3 (3.3) 1 (2.6) 1 (3.6)
Residential situation – living (n, %): n.s.
alone 33 (37.0) 14 (35.9) 6 (21.4)
with parents 1 (1.1) 0 0
with children 5 (5.6) 1 (2.6) 3 (10.7)
with cohabitant and with/without 
children
49 (55.0) 24 (61.5) 18 (64.3)
with friends 1 (1.1) 0 1 (3.6)
Marital status (n, %) n.s.
Single 18 (20.2) 7 (17.9) 4 (14.3)
Married 42 (47.2) 20 (51.3) 15 (53.6)
Separated 9 (10.1) 2 (5.1) 2 (7.1)
Divorced 17 (19.1) 9 (23.1) 5 (17.9)
Widowed 3 (3.4) 1 (2.6) 2 (7.1)
ap < 0.25, variable was included in the main effects model.Substance Abuse Treatment, Prevention, and Policy 2009, 4:15 http://www.substanceabusepolicy.com/content/4/1/15
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Predictors of outcome after 24 months (T4)
In the next step the importance of each variable included
in the model was verified and we obtained a preliminary
main effects model. The variables 'gender', 'number of
previous treatments' and 'attempted suicide' were
included in the main effect model. Table 4 presents the
final logistic regression model with three significant pre-
dictors: gender (OR = 0.2; 95%CI = 0.0–1.0; p < 0.05),
number of prior detoxifications (OR = 0.7; 95%CI = 0.6–
1.0; p < 0.05) and prior treatments for mental problems
(OR = 0.2; 95%CI = 0.1–0.7; p < 0.05).
Differences between patients with response or non-
response at T4
The groups differed in the retention rate (Pearson Chi2 =
8.1; df = 1; p < 0.01) and number of single (Pearson Chi2
= 4.3; df = 1; p < 0.05) and repeated relapses during treat-
ment (Pearson Chi2 = 11.3; df = 1; p < 0.01). More
patients with no response had dropped out (33.3% vs.
9.0%), had a single relapse (14.8% vs. 3.0%) or had
repeated relapses (25.9% vs. 3.0%) during the outpatient
treatment.
Discussion
Associations between demographic and clinical variables
and outcome in outpatient alcohol treatment were exam-
ined in a 2-year follow-up study. The overall treatment
results of the 24-month follow-up were in replication of
former results comparatively good, with a retention rate
over the 8-month treatment phase of 84% and a mini-
mum abstinence rate of 44% (all patients lost to follow-
up regarded as relapsers), and in line with previous find-
ings [8]. Of patients personally interviewed at follow-up
57% were abstinent and 21% improved. These results give
further evidence for the effectiveness of this outpatient
treatment for alcohol-dependent patients [cp. [6,8,36]].
The analyses identified female gender, number of prior
detoxifications and prior treatments for mental problems
as predictors of negative outcome. In addition, univariate
Table 3: Differences in alcohol-related, treatment-related and psychopathology-related variables (T0/T1) between abstinent and non-
abstinent patients 24 months after end of treatment (T4)
abstinent T4 (n = 39) non-abstinent T4 (n = 28) Differences abstinent vs. non-abstinent
Age of onset of alcohol use (years: M, SD) 14.4 (3.2) 14.4 (3.0) n.s.
Age of onset of regular alcohol use (years: M, SD) 21.1 (6.2) 21.8 (7.3) n.s.
Age of onset of alcohol dependence (years: M, SD) 32.0 (9.9) 32.2 (11.6) n.s.
Duration of alcohol dependence (years: M, SD) 15.0 (10.6) 13.2 (9.4) n.s.
Daily alcohol intake (g/day: M, SD) 193.2 (113.5) 157.8 (90.3) n.s.
Number of previous treatments (M, SD) for
alcohol
detoxification 2.5 (4.9) 4.7 (7.5) Mann-Whitney-U = 346.5*,b
rehabilitation 1.6 (8.0) 0.4 (0.8) n.s.
mental health problems 0.4 (0.6) 1.3 (2.3) Mann-Whitney-U = 411.5a,b
somatic problems 2.7 (2.4) 3.5 (2.7) Mann-Whitney-U = 432.0a,b
EuropASI Composite Score Medical status 0.18 (0.27) 0.21 (0.33) n.s.
EuropASI Composite Score Economic situation 0.21 (0.34) 0.33 (0.44) n.s.
EuropASI Composite Score Employment 0.18 (0.26) 0.16 (0.24) n.s.
EuropASI Composite Score Alcohol use 0.24 (0.07) 0.26 (0.12) n.s.
EuropASI Composite Score Drug use 0.00 (0.00) 0.01 (0.03) n.s.
EuropASI Composite Score Law 0.03 (0.09) 0.00 (0.00) n.s.
EuropASI Composite Score Family relationship 0.12 (0.19) 0.17 (0.24) n.s.
EuropASI Composite Score Social relationship 0.08 (0.16) 0.05 (0.12) n.s.
EuropASI Composite Score Psychiatric status 0.06 (0.09) 0.10 (0.14) n.s.
OCDS total (M, SD)c 5.5 (5.5) 7.8 (7.0) Mann-Whitney-U = 277.5a
Treatment drop out (n, %)c 2 (5.2) 4 (14.3) Pearson Chi2 = 1.5a; df = 1
Single relapse during treatment (n, %)c 1 (2.6) 1 (3.6) n.s.
Repeated relapse during treatment (n, %)c 0 2 (7.2) Pearson Chi2 = 2.7a; df = 1
Attempted suicide (n, %) 3 (7.7) 7 (25.0) Pearson Chi2 = 3.5*,b; df = 1
STAI (M, SD) 36.9 (7.3) 38.3 (7.9) n.s.
BDI (M, SD) 7.0 (7.1) 8.9 (6.0) Mann-Whitney-U = 301.5a.
*p < 0.05;ap < 0.25; b variable was included in the main effects model; c evaluated at T1.Substance Abuse Treatment, Prevention, and Policy 2009, 4:15 http://www.substanceabusepolicy.com/content/4/1/15
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analyses showed effects of suicide attempts. More of the
non-abstinent patients had a history of attempted sui-
cides.
These findings will be discussed in the light of previous
studies on this subject.
Demographics
In a quantitative and qualitative review of alcohol treat-
ment research, Jarvis [16]) found gender differences var-
ied as a function of time after treatment. During the first
year after treatment, women had a slightly superior treat-
ment outcome; however, this result had reversed one year
after treatment. In a review of 38 alcohol outcome studies,
Toneatto et al. [17] reported a better treatment outcome
of women in 58% of all studies reviewed and no gender
differences in the remaining 42%. The Project MATCH
Research Group [19] and McKay et al. [18] found better
treatment outcome in females, but other studies found no
gender differences [e.g. [20,21]]. Reasons for variation in
gender effects found in various studies include the differ-
ent definitions of relapse or a variation in the outcome cri-
teria, statistical methodology, prospective versus
retrospective design and sample characteristics [11]. The
same result like in the actual study, a less favourable out-
come of woman, was reported by Bottlender and Soyka
[8] and Anton et al. [22]. It seems that women have other
treatment needs than men. This is one result of a study by
Grella et al. [26]. They found differences in the treatment
needs of women and men [26]. It is possible that different
coping strategies are a reason for different demands in
alcohol treatment. Sigmond et al. [25] detected the use of
different coping strategies by women and men. Addition-
ally, women were found to show different patterns of
alcohol exposure and a different course of the disease [e.g.
[18,21], and [23]]. Special treatment settings such as out-
patient treatment may in some sequences not meet the
needs of some female patients. One feasible reason is that
female patients more often have an alcoholic spouse com-
pared to male participants [8]. In summary, an under-
standing of the differences in the treatment needs of
women and men seems to be helpful for the development
and provision of the most effective alcoholism treatment.
Alcohol-related variables
Unlike Diehl et al. [20] and others, we did not find any
predictive value of the duration of alcohol dependence.
The same is true for years of problem drinking, drinks per
drinking day [11,29] and age of onset for problem drink-
ing [13]. However, we found that the number of previous
detoxifications predicted outcome and further studies
showed that there is an association between this number
and the alcohol severity. These findings are in line with
the previous research indication prior treatment(s) to be a
negative predictor [7,10].
Psychopathology-related variables
In general, psychopathology and psychiatric comorbidity
is one of the most robust predictors of outcome in alcohol
treatment [14,28]. In our sample, patients who relapsed
during the 24-month period had more prior treatments
for mental problems and more attempted suicides than
the abstinent group. Furthermore previous treatments for
mental health problems were an significant outcome pre-
dictor. In a previous sample, Bottlender and Soyka [8] also
identified the number of previous (alcoholism) treat-
ments and the attempted suicides as risk factors for a neg-
ative treatment outcome.
Data on depression and outcome in alcoholism are
mixed. Greenfield et al. [30] used the BDI to analyse the
relation between time to first drink and current depressive
symptoms for 40 women and 61 men participating in an
inpatient alcoholism treatment programme. They found
no predictive value of depressive symptoms. In addition,
Bradizza et al. [34] investigated associations between
relapse to alcohol and depressive symptoms and found no
relationship between depressive symptomatology meas-
ured by BDI and resumption of alcohol use or relapse in
patients one year after discharge from inpatient treatment.
Like Greenfield et al. [30] and Bradizza et al. [34], we also
found no evidence that depressive symptoms (measured
Table 4: Differences between abstinent and non-abstinent patients 24 months after end of treatment (T4) – results of logistic 
regression analyses
abstinent T4 (n = 39) non-abstinent T4 (n = 28) OR Wald/df 95%CI
Gender (n, %) 0.2* 3.9/1 0.0–1.0
Male 26 (66.6) 15 (53.6)
Female 13 (33.3) 13 (46.3)
Number of previous treatments
(M, SD)
Detoxification 2.5 (4.9) 4.7 (7.5) 0.7* 3.7/1 0.6–1.0
For mental health problems 0.4 (0.6) 1.3 (2.3) 0.2* 3.9/1 0.1–0.7
*p < 0.05.Substance Abuse Treatment, Prevention, and Policy 2009, 4:15 http://www.substanceabusepolicy.com/content/4/1/15
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with the BDI) have impact on treatment outcome after 24
months. The same applied to anxiety symptoms assessed
by STAI. A potential reason for the lack of a relationship
between depressive and anxiety symptoms and relapse is
the severity of the symptoms, as reflected by the scores: at
admission, the scores of STAI and of BDI ranged in the
lower to middle range; the patients' scores were not scat-
tered over such a wide range that a clear differentiation
would be possible.
In summary, depressive symptoms measured with the BDI
and anxiety symptoms measured with the STAI did not
predict treatment outcome in a less severely affected sam-
ple of patients. Nevertheless, the psychiatric status is not
irrelevant as the relapsed patients were treated more fre-
quently for mental disorders.
According the a priori hypothesis:
Female gender was one of the predictors of a negative
treatment outcome: treatment outcome was triggered by
gender, number of previous detoxifications and of previ-
ous treatments for mental problems. A recent systematic
review also showed gender to be predictive as was severity
of dependence and baseline alcohol consumption [10].
Surprisingly, treatment drop out was not a predictor of
relapsing after treatment. The role of previous treatments
is very interesting according the allocation to the most
suitable current kind of treatment. In a further study we
aim to investigate the allocation to three kinds of treat-
ments.
Our study has some limitations. The selection procedure
of patients was done before study start. Patients were par-
ticipants of an outpatient treatment programme and had
a stabile residential situation, a rather good level of social
adjustment, as indicated by the fairly low unemployment
rate, among others. The sample size was rather small; dif-
ferences may have been larger if all patients had partici-
pated in the 24-month follow-up. Still the rate of patients
personally interviewed after 2 years was fairly good.
Finally we did not integrate a control group.
Matching patients to different types of treatment on the
basis may help to improve outcome but research has
failed to establish reliable predictors in that area [19]. In
general, social variables have a high predictive value [46].
Our data are in line with these findings.
Conclusion
Despite the limitations which reduce generalizability, the
study indicates that alcohol outpatient treatment is an
effective treatment option at least in socially more stable
patients. Data from this follow-up study confirm the role
of certain clinical outcome predictors. Female patients
and patients treated more frequently for mental problems
were more likely to have a poor 24-month outcome.
These findings are basically in line with results of a previ-
ous follow-up study [8]. Future research may especially
focus on setting and gender effects to improve allocation
of patients to different treatment settings.
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